Daniel O. Landy, EVP and President of OZ Fund at UMH Properties, Inc., filed a Form 4 on November 12, 2026, reporting the exercise of 2,500 stock options in UMH Properties, Inc. common shares on that same date.
GS Finance Corp. filed a Free Writing Prospectus on November 12, 2026, describing Contingent Income Auto-Callable Securities linked to the Class A common stock of Alphabet Inc., with a stated maturity date expected to be November 26, 2029.
First Manhattan Co. LLC, FMC Group Holdings LP, and First Manhattan Management LLC jointly filed an amended Schedule 13G with the SEC on November 12, 2026, disclosing their beneficial ownership of common stock in NN Inc. as of September 30, 2026.
Weiss Asset Management LP, WAM GP LLC, and Andrew M. Weiss filed a Schedule 13G with the SEC on November 12, 2026, disclosing aggregate beneficial ownership of 4,063,438 shares of McEwen Inc. common stock, representing 6.2% of the class as of September 30, 2026.
NYSE American LLC filed a Form 25 on November 12, 2026, notifying the SEC of the removal of TechCreate Group Ltd.'s Class A Ordinary Shares from listing and registration under Section 12(b) of the Securities Exchange Act of 1934.
Exicure, Inc. filed a definitive proxy statement (DEF 14A) on November 12, 2026, calling stockholders to a 2026 Annual and Special Meeting to be held virtually on December 2, 2026, at 5:00 p.m. Central Time, with six proposals on the ballot including a request …
Warren David Cheesman, Acting Chief Executive Officer of CVD Equipment Corporation, filed a statement of changes in beneficial ownership on November 12, 2026, reporting the grant of stock options on November 10, 2026.
Director Richard T. Du Moulin filed a Form 144 notice on November 12, 2026, disclosing a proposed sale of 50,000 common shares of Pangaea Logistics Solutions Ltd. through Wells Fargo Clearing Services.
A Form 144 notice of proposed securities sale was filed on November 12, 2026, by Gilbert Greg M., a policy-making officer of Concentra Group Holdings Parent, Inc., disclosing intent to sell 18,194 shares of common stock on NYSE.
Sanket Shah, General Counsel of Mesa Laboratories Inc /CO/, filed an amended Form 3/A with the SEC on November 12, 2026, reporting initial beneficial ownership of 2,306 restricted stock units in the company's common stock as of November 10, 2026.